Clinical Scorecard: Independent Prediction of Left Ventricular Aneurysm in STEMI Patients by Fibrinogen-to-Albumin Ratio: Findings from a Retrospective Cohort Analysis

At a Glance

Key Highlights

• Elevated fibrinogen-to-albumin ratio (FAR) is independently associated with increased risk of LVA.
• The combined prediction model demonstrated high discrimination with an AUC of 0.933.
• Temporal validation confirmed the model's performance with an AUC of 0.934.

Guideline-Based Recommendations

Diagnosis

• STEMI diagnosed according to the Fourth Universal Definition of Myocardial Infarction.

Management

• Primary percutaneous coronary intervention (pPCI) performed within 24 hours of symptom onset.

Monitoring & Follow-up

• Monitor inflammatory biomarkers, including FAR, for risk assessment of LVA.

Risks

• Patients with LVA have a heightened risk of heart failure, malignant arrhythmias, thromboembolic events, and sudden cardiac death.

Patient & Prescribing Data

1,245 STEMI patients in the development cohort.

High FAR indicates a need for closer monitoring and potential intervention strategies.

Clinical Best Practices

• Incorporate FAR in risk assessment protocols for STEMI patients.
• Utilize combined models for better prediction of LVA risk.

Related Resources & Content

• Clinical Research Ethics Committee of Renmin Hospital of Wuhan University